Literature DB >> 34980883

Sex-specific alterations of cortical morphometry in treatment-naïve patients with major depressive disorder.

Xinyue Hu1,2, Lianqing Zhang1,2, Kaili Liang1,2, Lingxiao Cao1,2, Jing Liu1,2, Hailong Li1,2, Yingxue Gao1,2, Xinyu Hu1,2, Yongbo Hu1,2, Weihong Kuang3, John A Sweeney1,4, Qiyong Gong5,6,7, Xiaoqi Huang8,9,10.   

Abstract

Major depressive disorder (MDD) shows sex differences in terms of incidence and symptoms, but the neurobiological basis underlying these sex differences remains to be clarified. High resolution T1-weighted Magnetic Resonance Imaging (MRI) scans were obtained from 123 non-comorbid treatment-naïve individuals with MDD and 81 age-, sex-, and handedness-matched healthy controls (HCs). MRI data were preprocessed with FreeSurfer software and four cortical measures were extracted: cortical thickness (CT), surface area (SA), cortical volume (CV), and local gyrification index (LGI). We tested for both sex-specific and sex-nonspecific patterns of cortical anatomic alterations. Regardless of sex, individuals with MDD showed significantly higher LGI in posterior cortex relative to HCs. Significant sex-by-group interactions were observed, and subsequent post-hoc analyses revealed that female individuals with MDD showed significantly lower SA in left ventrolateral prefrontal cortex (vlPFC), lower CV in right rostromedial prefrontal cortex (rmPFC), and higher LGI in left visual cortex compared with sex-matched HCs, whereas the opposite patterns of significant effects were seen in male individuals with MDD relative to their sex-matched HCs. Thus, sex-nonspecific and specific morphometric differences from HCs were found in posterior cortex, while in PFC alterations were highly sex-specific early in the illness course. This may involve sex-specific alterations in brain development or processes related to illness onset. These findings highlight the presence and regional distribution of generalized as well as sex-specific alterations of brain neurobiology in MDD.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Year:  2022        PMID: 34980883      PMCID: PMC9485252          DOI: 10.1038/s41386-021-01252-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  63 in total

1.  Sex differences in thickness, and folding developments throughout the cortex.

Authors:  A Kadir Mutlu; Maude Schneider; Martin Debbané; Deborah Badoud; Stephan Eliez; Marie Schaer
Journal:  Neuroimage       Date:  2013-05-28       Impact factor: 6.556

2.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

Review 3.  Specifying the brain anatomy underlying temporo-parietal junction activations for theory of mind: A review using probabilistic atlases from different imaging modalities.

Authors:  Matthias Schurz; Matthias G Tholen; Josef Perner; Rogier B Mars; Jerome Sallet
Journal:  Hum Brain Mapp       Date:  2017-06-13       Impact factor: 5.038

Review 4.  Reframing sexual differentiation of the brain.

Authors:  Margaret M McCarthy; Arthur P Arnold
Journal:  Nat Neurosci       Date:  2011-05-25       Impact factor: 24.884

Review 5.  Understanding the broad influence of sex hormones and sex differences in the brain.

Authors:  Bruce S McEwen; Teresa A Milner
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

6.  Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity.

Authors:  Leah H Rubin; Li Yao; Sarah K Keedy; James L Reilly; Jeffrey R Bishop; C Sue Carter; Hossein Pournajafi-Nazarloo; Lauren L Drogos; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Scot K Hill; Wei Liao; Gong-Jun Ji; Su Lui; John A Sweeney
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 7.  The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.

Authors:  Emily L Belleau; Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-10-10       Impact factor: 13.382

8.  Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression.

Authors:  Ramin S Hastings; Ramin V Parsey; Maria A Oquendo; Victoria Arango; J John Mann
Journal:  Neuropsychopharmacology       Date:  2004-05       Impact factor: 7.853

9.  Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group.

Authors:  L Schmaal; D J Veltman; T G M van Erp; P G Sämann; T Frodl; N Jahanshad; E Loehrer; H Tiemeier; A Hofman; W J Niessen; M W Vernooij; M A Ikram; K Wittfeld; H J Grabe; A Block; K Hegenscheid; H Völzke; D Hoehn; M Czisch; J Lagopoulos; S N Hatton; I B Hickie; R Goya-Maldonado; B Krämer; O Gruber; B Couvy-Duchesne; M E Rentería; L T Strike; N T Mills; G I de Zubicaray; K L McMahon; S E Medland; N G Martin; N A Gillespie; M J Wright; G B Hall; G M MacQueen; E M Frey; A Carballedo; L S van Velzen; M J van Tol; N J van der Wee; I M Veer; H Walter; K Schnell; E Schramm; C Normann; D Schoepf; C Konrad; B Zurowski; T Nickson; A M McIntosh; M Papmeyer; H C Whalley; J E Sussmann; B R Godlewska; P J Cowen; F H Fischer; M Rose; B W J H Penninx; P M Thompson; D P Hibar
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

10.  Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.

Authors:  L Schmaal; D P Hibar; P G Sämann; G B Hall; B T Baune; N Jahanshad; J W Cheung; T G M van Erp; D Bos; M A Ikram; M W Vernooij; W J Niessen; H Tiemeier; A Hofman; K Wittfeld; H J Grabe; D Janowitz; R Bülow; M Selonke; H Völzke; D Grotegerd; U Dannlowski; V Arolt; N Opel; W Heindel; H Kugel; D Hoehn; M Czisch; B Couvy-Duchesne; M E Rentería; L T Strike; M J Wright; N T Mills; G I de Zubicaray; K L McMahon; S E Medland; N G Martin; N A Gillespie; R Goya-Maldonado; O Gruber; B Krämer; S N Hatton; J Lagopoulos; I B Hickie; T Frodl; A Carballedo; E M Frey; L S van Velzen; B W J H Penninx; M-J van Tol; N J van der Wee; C G Davey; B J Harrison; B Mwangi; B Cao; J C Soares; I M Veer; H Walter; D Schoepf; B Zurowski; C Konrad; E Schramm; C Normann; K Schnell; M D Sacchet; I H Gotlib; G M MacQueen; B R Godlewska; T Nickson; A M McIntosh; M Papmeyer; H C Whalley; J Hall; J E Sussmann; M Li; M Walter; L Aftanas; I Brack; N A Bokhan; P M Thompson; D J Veltman
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.